DP3 Type 1 Diabetes Targeted Research Award
Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)
This FOA invites applications for ancillary studies using archived samples from selected diabetes clinical trials and studies. Ancillary studies are expected to generate scientific discoveries on type 1 diabetes primary pathogenesis or the pathogenesis of complications, and biomarkers of disease progression or clinical responses to interventions.
|Letter of Intent Due Date|
March 10, 2014
|Application Due Date|
April 10, 2014, by 5:00 PM local time of applicant organization.